Joint EMA-ECDC press briefing on current state of respiratory diseases and treatments in the EU/EEA
As autumn season approaches the EMA and ECDC held a press briefing to provide latest information on respiratory diseases as well as vaccines and treatments available
|
9th Influenza Conference 2023
The Influenza B/Yamagata lineage appears to become extinct: implications for quadrivalent influenza vaccines?
SPI08 session from #ESWI2023
|
9th Influenza Conference 2023
Global health perspectives on acute respiratory virus disease and how to ensure an equitable response/access to vaccines and therapy
SPI04 session from #ESWI2023
|
9th Influenza Conference 2023
Communication: Raising awareness on the burden of disease
SPI06 session from #ESWI2023
|
9th Influenza Conference 2023
Intervention strategies for the management of ARVI
SPI05 session from #ESWI2023
|
9th Influenza Conference 2023
ESWI Symposium: RSV Looking towards the future
SPI07 session from #ESWI2023
|
9th Influenza Conference 2023
Best practices in vaccination programmes for risk groups and healthcare workers
SPI03 session from #ESWI2023
|
9th Influenza Conference 2023
Why influenza and RSV disease are a priority for policy makers
SPI01 session from #ESWI2023
